Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Obtains Rights to Orchid s SNP-Scoring Technology

NEW YORK, Nov. 28 – Invitrogen has acquired the exclusive rights to develop and market genotyping products utilizing Orchid’s SNP-scoring primer extension technology in a 96-well format, the companies said Wednesday.

Under the terms of the deal, Invitrogen of San Diego will pay Orchid of Princeton, NJ, a royalty on kit sales. 

"The agreement with Orchid is consistent with our strategy of in-licensing high potential technologies,” Lyle Turner, CEO of Invitrogen, said in a statement. “Now we can bring the premier technology for accurate, rapid and flexible SNP genotyping to scientists worldwide."

Invitrogen has also obtained the rights to provide customers with access to the SNP primer design algorithms Orchid provides through its AutoPrimer.com website. 

Orchid said that it would benefit from Invitrogen’s marketing and sales infrastructure.

"With their worldwide sales and marketing coverage, Invitrogen is an acknowledged leader in providing technically advanced reagent kits to thousands of laboratories," Jack Ball, senior vice president and general manager of Orchid's Life Sciences Group, said. 

Orchid's proprietary SNP-IT primer extension technology provides is designed to allow researchers to generate hundreds of SNP genotypes per day.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.